Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three upcoming investor conferences.
Stifel 2023 Immunology and Inflammation Virtual Summit
Jefferies Cell & Genetic Medicine Summit
2023 Cantor Global Healthcare Conference
Webcast of the presentations will be available on the News and Events section of Gracell’s investor website. A replay of the webcast will be available for 30 days following the event.
Media contact Marvin Tang [email protected] Investor contact Gracie Tong [email protected]
Culture as a Competitive Advantage
From Analyst to Implementer: Insights from an Insider
Securing Critical Operationâ€¦.Shedding Light on OT and Cybersecurity Risks